查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825941

2025 年全球无晶体眼市场报告

Aphakia Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，无晶体眼市场规模迅速扩张，从2024年的16.8亿美元成长至2025年的18.9亿美元，复合年增长率达12.3%。这段时期的成长归因于白内障盛行率的上升、先进手术技术的进步、眼部健康意识的增强、眼科手术数量的增加以及临床检查数量的增加。

预计未来几年无晶体眼市场将快速成长，到2029年将达到30.1亿美元，复合年增长率为12.3%。预测期内的增长归因于对先进人工水晶体(IOL)的需求不断增长、眼科手术数量不断增加、眼外伤患病率不断上升、眼科手术医疗旅游的兴起以及对个性化治疗方案的日益关注。预测期内的主要趋势包括数位技术在白内障手术中的整合、微创手术技术的进步、晶状体材料的改进、患者个性化数据分析的引入以及机器人辅助手术的普及。

无晶体眼是指眼晶状体有缺陷，可能导致严重的视力障碍，因为水晶体在将光线聚焦到视网膜方面起着至关重要的作用。这种疾病可能由手术摘除水晶体（白内障手术或其他手术）、外伤或其他导致自然水晶体丧失的疾病所引起。

无晶体眼市场主要分为三大类：先天性无晶体眼、手术性无晶体眼及后天性无晶体眼。先天性无晶体眼是指出生时单眼或双眼缺乏水晶体。治疗方法，包括框架眼镜、隐形眼镜、人工水晶体植入和屈光矫正手术，最终用户包括医院和眼科诊所。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗保健领域产生了重大影响，尤其是对基本医疗设备、诊断设备和药品的供应。医院和医疗机构正疲于应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本，而这些产品中的许多在国内的替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力，一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，导致供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供了无晶状体市场统计数据，例如全球市场规模、区域份额、市场份额占比较高的竞争对手、详细的无晶状体市场细分、市场趋势以及无晶状体行业的商机，为您提供在无晶状体行业取得成功所需的数据。本无晶体市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供全面的观点，助您一臂之力。

未来五年12.3%的成长率预测比我们先前的预测略有下降，下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会对美国眼科手术构成重大挑战，因为它会限制从以色列和德国进口的高端人工水晶体和无晶体眼接触镜的获取，从而可能损害视力康復效果并增加白内障手术的成本。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响，其影响也将更加广泛。

白内障盛行率的不断上升预计将推动未来无晶体眼市场的成长。白内障是指眼球水晶体变得混浊，导致视力模糊的一种疾病。导致白内障发病率上升的因素包括人口老化、糖尿病盛行率上升、过度日晒、吸烟和营养不良。白内障会导致无晶体眼，需要透过手术摘除眼球的天然水晶体，去除混浊的水晶体。例如，根据《未来世代福祉法案》（WFG）进行的英国眼科统计调查（2021-2023 年）的数据，2022 年至 2023 年，英国住院的白内障患者人数约为 16,500 人，比前一年增加了 23.7%。因此，白内障发病率的上升正在推动无晶体眼市场的发展。

无晶体眼市场的主要参与企业正在开发用于矫正老花眼的人工水晶体(IOL)，旨在改善视力结果并提高患者满意度。这些人工水晶体透过恢復视力和矫正老花眼来帮助无晶体眼患者，使他们无需额外佩戴眼镜即可在不同距离获得清晰的视力。例如，2023 年 11 月，瑞士手术设备公司爱尔康 (Alcon) 在加拿大推出了 Clareon Vivity。这款创新的非衍射、扩展景深 (EDOF) 人工水晶体可最大限度地减少视力障碍并提供高品质的视觉。 Clareon Vivity IOL 专为治疗无晶体眼而设计，无晶体眼是由于白内障手术中摘除自然水晶体而导致的疾病。它采用 X-wave 技术进行聚焦而不会分裂波前，从而最大限度地减少光晕并提供更准确的视觉体验。这项进步标誌着无晶体眼市场向前迈出了重要一步，为白内障患者提供了更好的老花眼矫正解决方案。

2024年7月，美国眼科护理服务供应商iCare Health Solutions收购了Beraja Medical Group，收购金额未揭露。此次收购旨在拓展iCare Health Solutions的眼科护理服务，并改善病患治疗效果。此次收购旨在提升优质医疗服务的可近性，同时将iCare的成熟专业技术整合到iCare网路中。此外，收购还确保了本地业务永续营运，并为当地居民保留了熟悉的员工队伍。 Beraja Medical Group专注于综合眼科，专注于先进的眼科护理和美容服务，包括与无晶体眼相关的服务。

无晶体眼市场由提供诊断、人工人工水晶体(IOL) 手术植入、术后护理和復健等服务的营业单位所获得的收益所构成。市场规模还包括服务提供者销售的或包含在其服务产品中的任何相关产品的价值。无晶体眼市场还包括人工水晶体(IOL)、隐形眼镜、眼镜和眼部植入的销售。此市场价值是“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球无晶体症：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球无水晶体眼市场：成长率分析
  • 全球无晶体眼市场表现：规模与成长，2019-2024 年
  • 全球无晶体眼市场预测：2024-2029 年、2034 年规模与成长
  • 全球无晶体眼：总潜在市场（TAM）

第六章 市场细分

  • 全球无晶体眼市场类型、表现及预测（2019-2024、2024-2029、2034）
  • 先天性无晶体
  • 手术性无晶体眼
  • 后天无晶体眼
  • 全球无晶体眼市场（依治疗、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 眼镜
  • 隐形眼镜
  • 人工水晶体植入术
  • 屈光矫正手术
  • 全球无晶体眼市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 眼科诊所
  • 其他的
  • 全球无晶体市场：先天性无晶体细分、类型、表现及预测（2019-2024、2024-2029、2034）
  • 原发性无晶体眼
  • 继发性次发性眼
  • 全球无晶体眼市场：手术性无晶体眼细分市场、按类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 白内障手术后
  • 水晶体脱位手术后
  • 全球无晶体眼市场：按类型、绩效和预测分類的无晶体眼细分市场，2019-2024 年、2024-2029 年、2034 年
  • 外伤性无晶体症
  • 疾病引起的无晶体症

第七章 区域和国家分析

  • 全球无晶体眼市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球无晶体眼市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 无晶体市场：竞争格局
  • 无晶体市场：公司简介
    • Johnson & Johnson Services Inc.
    • Aetna Inc.
    • Alcon Laboratories Inc.
    • Hoya Corporation
    • CooperVision Inc.

第31章：其他领先和创新企业

  • Carl Zeiss AG
  • Santen Pharmaceutical Co. Ltd.
  • Appasamy Associates
  • Aurolab
  • Rayner Intraocular Lenses Limited
  • VSY BIoTechnology
  • Ophtec BV
  • SIFI SpA
  • Aaren Scientific Inc.
  • Mediphacos
  • Hanita Lenses Ltd.
  • Menicon Co. Ltd.
  • Lenstec Inc.
  • Morcher GmbH
  • Bausch & Lomb Incorporated

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年无水晶体市场：提供新机会的国家
  • 2029 年无晶体市场：细分领域带来新机会
  • 2029 年无晶体市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r31605u

Aphakia is defined as the absence of the crystalline lens in the eye, which can result in significant visual impairment since the lens plays a vital role in focusing light onto the retina. This condition may arise from the surgical removal of the lens (such as during cataract surgery), trauma, or other medical conditions that result in the loss of the natural lens.

The primary categories within the aphakia market include congenital aphakia, surgical aphakia, and acquired aphakia. Congenital aphakia describes a condition present at birth, where an individual is born without a natural lens in one or both eyes. Various treatment options are available, including spectacles, contact lenses, intraocular lens implantation, and refractive surgery, with end users comprising hospitals, ophthalmic clinics, and other facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The aphakia market research report is one of a series of new reports from The Business Research Company that provides aphakia market statistics, including aphakia industry global market size, regional shares, competitors with a aphakia market share, detailed aphakia market segments, market trends, and opportunities, and any further data you may need to thrive in the aphakia industry. This aphakia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aphakia market size has grown rapidly in recent years. It will grow from $1.68 billion in 2024 to $1.89 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increasing prevalence of cataracts, growth in advanced surgical techniques, increasing awareness about eye health, rising number of eye surgeries, increasing number of clinical trials.

The aphakia market size is expected to see rapid growth in the next few years. It will grow to $3.01 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing demand for advanced intraocular lenses (IOLs), growth in ophthalmic surgical procedures, increasing prevalence of eye trauma, growth in medical tourism for eye surgeries, increasing focus on personalized treatment options. Major trends in the forecast period include integration of digital technology in cataract surgery, advancements in minimally invasive surgical techniques, advancements in lens materials, implementation of patient specific data analytics, adoption of robotic assisted surgery.

The forecast of 12.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. ophthalmic surgery by restricting access to premium intraocular lenses and aphakic contact lenses imported from Israel and Germany, potentially compromising visual rehabilitation outcomes and increasing cataract surgery costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of cataracts is anticipated to drive the growth of the aphakia market in the future. Cataracts are a condition in which the lens of the eye becomes opaque, resulting in blurred vision. Factors contributing to the rise in cataract cases include an aging population, a higher prevalence of diabetes, excessive sun exposure, smoking, and inadequate nutrition. The condition leads to aphakia, as surgery to remove the cloudy lens necessitates the extraction of the eye's natural lens. For example, data from the National UK Eye Care Statistics Survey (2021-2023), conducted by the Well-being of Future Generations Act (WFG), revealed that there were approximately 16,500 cataract admissions in the UK during 2022-2023, reflecting a 23.7% increase from the prior year. Consequently, the growing occurrence of cataracts is boosting the aphakia market.

Key players in the aphakia market are developing presbyopia-correcting intraocular lenses (IOLs) aimed at improving visual outcomes and enhancing patient satisfaction. These IOLs assist individuals with aphakia by restoring vision and correcting presbyopia, allowing clear vision at various distances without the need for additional eyewear. For instance, in November 2023, Alcon, a surgical equipment company based in Switzerland, introduced the Clareon Vivity in Canada. This innovative nondiffractive extended depth of focus (EDOF) IOL delivers high-quality vision with minimal visual disturbances. The Clareon Vivity IOL is specifically designed for treating aphakia, a condition arising from the removal of the natural lens during cataract surgery. By employing x-wave technology, it enhances focus without splitting the wavefront, thus minimizing halos and providing a more precise visual experience. This advancement represents a significant step forward in the aphakia market, offering cataract patients an improved solution for presbyopia correction.

In July 2024, iCare Health Solutions, a US-based ocular care services provider, acquired Beraja Medical Group for an undisclosed sum. This acquisition aims to broaden iCare Health Solutions' eyecare offerings and enhance patient outcomes. The initiative seeks to improve access to high-quality care while integrating established expertise into iCare's network. Additionally, it ensures the continuation of local operations and maintains familiar staff for the community. Beraja Medical Group specializes in comprehensive ophthalmology, with a focus on advanced eye care and aesthetic services, including those related to aphakia.

Major companies operating in the aphakia market are Johnson & Johnson Services Inc., Aetna Inc., Alcon Laboratories Inc., Hoya Corporation, CooperVision Inc., Carl Zeiss AG, Santen Pharmaceutical Co. Ltd., Appasamy Associates, Aurolab, Rayner Intraocular Lenses Limited, VSY Biotechnology, Ophtec BV, SIFI SpA, Aaren Scientific Inc., Mediphacos, Hanita Lenses Ltd., Menicon Co. Ltd., Lenstec Inc., Morcher GmbH, Bausch & Lomb Incorporated, Bohus BioTech AB, Nidek Co. Ltd., Swiss Advanced Vision AG, UltraVision CLPL, Medennium Inc.

North America was the largest region in the aphakia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aphakia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aphakia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aphakia market consists of revenues earned by entities by providing services such as diagnosis, surgical implantation of intraocular lenses (IOLs), postoperative care, and rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The aphakia market also includes sales of intraocular lenses (IOLs), contact lenses, spectacles, and ocular implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aphakia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aphakia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aphakia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The aphakia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Congenital Aphakia; Surgical Aphakia; Acquired Aphakia
  • 2) By Treatment: Spectacles; Contact Lenses; Intraocular Lens Implantation; Refractive Surgery
  • 3) By End User: Hospitals; Ophthalmic clinics; Other End Users
  • Subsegments:
  • 1) By Congenital Aphakia: Primary Aphakia; Secondary Aphakia
  • 2) By Surgical Aphakia: Post-Cataract Surgery; Post-Lens Dislocation Surgery
  • 3) By Acquired Aphakia: Trauma-Induced Aphakia; Disease-Induced Aphakia
  • Companies Mentioned: Johnson & Johnson Services Inc.; Aetna Inc.; Alcon Laboratories Inc.; Hoya Corporation; CooperVision Inc.; Carl Zeiss AG; Santen Pharmaceutical Co. Ltd.; Appasamy Associates; Aurolab; Rayner Intraocular Lenses Limited; VSY Biotechnology; Ophtec BV; SIFI SpA; Aaren Scientific Inc.; Mediphacos; Hanita Lenses Ltd.; Menicon Co. Ltd.; Lenstec Inc.; Morcher GmbH; Bausch & Lomb Incorporated; Bohus BioTech AB; Nidek Co. Ltd.; Swiss Advanced Vision AG; UltraVision CLPL; Medennium Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Aphakia Market Characteristics

3. Aphakia Market Trends And Strategies

4. Aphakia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Aphakia Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Aphakia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Aphakia Market Growth Rate Analysis
  • 5.4. Global Aphakia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Aphakia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Aphakia Total Addressable Market (TAM)

6. Aphakia Market Segmentation

  • 6.1. Global Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Congenital Aphakia
  • Surgical Aphakia
  • Acquired Aphakia
  • 6.2. Global Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spectacles
  • Contact Lenses
  • Intraocular Lens Implantation
  • Refractive Surgery
  • 6.3. Global Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ophthalmic clinics
  • Other End Users
  • 6.4. Global Aphakia Market, Sub-Segmentation Of Congenital Aphakia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Primary Aphakia
  • Secondary Aphakia
  • 6.5. Global Aphakia Market, Sub-Segmentation Of Surgical Aphakia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Post-Cataract Surgery
  • Post-Lens Dislocation Surgery
  • 6.6. Global Aphakia Market, Sub-Segmentation Of Acquired Aphakia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Trauma-Induced Aphakia
  • Disease-Induced Aphakia

7. Aphakia Market Regional And Country Analysis

  • 7.1. Global Aphakia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Aphakia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Aphakia Market

  • 8.1. Asia-Pacific Aphakia Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Aphakia Market

  • 9.1. China Aphakia Market Overview
  • 9.2. China Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Aphakia Market

  • 10.1. India Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Aphakia Market

  • 11.1. Japan Aphakia Market Overview
  • 11.2. Japan Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Aphakia Market

  • 12.1. Australia Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Aphakia Market

  • 13.1. Indonesia Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Aphakia Market

  • 14.1. South Korea Aphakia Market Overview
  • 14.2. South Korea Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Aphakia Market

  • 15.1. Western Europe Aphakia Market Overview
  • 15.2. Western Europe Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Aphakia Market

  • 16.1. UK Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Aphakia Market

  • 17.1. Germany Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Aphakia Market

  • 18.1. France Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Aphakia Market

  • 19.1. Italy Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Aphakia Market

  • 20.1. Spain Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Aphakia Market

  • 21.1. Eastern Europe Aphakia Market Overview
  • 21.2. Eastern Europe Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Aphakia Market

  • 22.1. Russia Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Aphakia Market

  • 23.1. North America Aphakia Market Overview
  • 23.2. North America Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Aphakia Market

  • 24.1. USA Aphakia Market Overview
  • 24.2. USA Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Aphakia Market

  • 25.1. Canada Aphakia Market Overview
  • 25.2. Canada Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Aphakia Market

  • 26.1. South America Aphakia Market Overview
  • 26.2. South America Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Aphakia Market

  • 27.1. Brazil Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Aphakia Market

  • 28.1. Middle East Aphakia Market Overview
  • 28.2. Middle East Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Aphakia Market

  • 29.1. Africa Aphakia Market Overview
  • 29.2. Africa Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Aphakia Market Competitive Landscape And Company Profiles

  • 30.1. Aphakia Market Competitive Landscape
  • 30.2. Aphakia Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Aetna Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Alcon Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Hoya Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. CooperVision Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Aphakia Market Other Major And Innovative Companies

  • 31.1. Carl Zeiss AG
  • 31.2. Santen Pharmaceutical Co. Ltd.
  • 31.3. Appasamy Associates
  • 31.4. Aurolab
  • 31.5. Rayner Intraocular Lenses Limited
  • 31.6. VSY Biotechnology
  • 31.7. Ophtec BV
  • 31.8. SIFI SpA
  • 31.9. Aaren Scientific Inc.
  • 31.10. Mediphacos
  • 31.11. Hanita Lenses Ltd.
  • 31.12. Menicon Co. Ltd.
  • 31.13. Lenstec Inc.
  • 31.14. Morcher GmbH
  • 31.15. Bausch & Lomb Incorporated

32. Global Aphakia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aphakia Market

34. Recent Developments In The Aphakia Market

35. Aphakia Market High Potential Countries, Segments and Strategies

  • 35.1 Aphakia Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Aphakia Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Aphakia Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer